Piper Jaffray Assumes CRISPR Therapeutics (CRSP) at Overweight – StreetInsider.com
|
Piper Jaffray Assumes CRISPR Therapeutics (CRSP) at Overweight
StreetInsider.com Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here. Piper Jaffray assumes coverage on CRISPR Therapeutics (NASDAQ: CRSP) with a … CRISPR Therapeutics AG (:CRSP) Insider Watch on The Stock |
